Phase I Trial of the Topical Microbicide BufferGel

Sponsors: Division of AIDS, US National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)

Protocol Summary: To evaluate the safety of BufferGel, a spermicidal microbicide that acidifies semen and maintains the protective acidity of the vagina, in a high-dose trial.

Year: 1999

Investigator: Z.M. Chirenje, MD, FRCOG

Location: Spilhaus CRS

Comments are closed.

Website by Canton Becker